The Role of Endocan in Cardiometabolic Disorders
Open Access
- 8 May 2023
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 13 (5) , 640
Abstract
Discovered two decades ago, endocan still represents an intriguing biomarker related to inflammation. Endocan is a soluble dermatan sulphate proteoglycan secreted by endothelial cells. Its expression is observed in tissues related to the enhanced proliferation, especially hepatocytes, lungs, kidneys, etc. Endocan has been investigated in many cardiometabolic disorders that are tightly connected with inflammation, such as type 2 diabetes mellitus, hypertension, atherosclerotic cardiovascular disease, kidney disease, obesity, polycystic ovary syndrome, metabolic syndrome, non-alcoholic fatty liver disease, etc. In this narrative, comprehensive review of the currently available literature, special attention will be paid to the role of endocan in the broad spectrum of cardiometabolic disorders. Since endocan has emerged as a novel endothelial dysfunction marker, the discovery of potential therapeutic strategies for patients with certain cardiometabolic risk factors would be of great importance to delay or even prevent the onset and progression of related complications, mainly cardiovascular.Keywords
This publication has 75 references indexed in Scilit:
- Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with HypertensionGenetic Testing and Molecular Biomarkers, 2015
- The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitusClinica Chimica Acta, 2015
- Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney diseaseKidney International, 2014
- Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartanBlood Pressure, 2014
- The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth FactorCurrent Eye Research, 2014
- Endocan—A Novel Inflammatory Indicator in Newly Diagnosed Patients With HypertensionAngiology, 2014
- Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In VivoJournal of Cellular Physiology, 2013
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver diseaseHepatology, 2013
- Adipose Tissue and Circulating Endothelial Cell Specific Molecule-1 in Human ObesityHormone and Metabolic Research, 2006
- Endothelial Cell Specific Molecule-1 - A Newly Identified Protein in AdipocytesHormone and Metabolic Research, 2003